Stability over time of immature platelet fraction and comparison between EDTA and citrated whole blood samples

Marc Michel Noel1, Guillaume Feugray2,3, Fiston Kasonga1

  • 1CHU Rouen, Vascular Hemostasis Unit, Rouen, France.

Insights

Immature platelet (IP) measurements are stable up to 24 hours in EDTA and 6 hours in citrate samples. This research supports the clinical utility of immature platelet fraction (IPF) analysis in diagnosing thrombocytopenia.

Area of Science:

  • Hematology
  • Clinical Pathology
  • Diagnostic Research

Background:

  • Immature platelets (IP) are young, active platelets crucial for diagnosing thrombocytopenia.
  • Understanding IP variability and stability is essential for reliable clinical application.

Purpose of the Study:

  • To compare immature platelet (IP) variability in citrate versus EDTA anticoagulant samples.
  • To determine the stability of IP measurements over time in both sample types.

Main Methods:

  • Fifty-six patients, including 28 with thrombocytopenia, were analyzed.
  • Platelet counts and immature platelet fraction (IPF) were measured using Sysmex XN-9000 (impedancemetry and fluorimetry).
  • IPF and absolute immature platelet count (A-IPC) were determined via fluorescent methods.

Main Results:

  • No significant difference in IPF was found between EDTA (7.74±6.68%) and citrate (8.45±7.37%) samples.
  • IPF measurements showed stability up to 24 hours in EDTA and 6 hours in citrate samples.
  • Bland-Altman analysis confirmed stability within specified timeframes for both anticoagulants.

Conclusions:

  • IP measurements are reliable up to 24 hours in EDTA and 6 hours in citrate samples.
  • These findings support the potential clinical utility of IPF analysis.
  • Further standardization is needed to fully define IPF's role in clinical practice.
Abstract